The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Taiho Pharmaceutical (Inst)
TLR6 polymorphism associated with overall survival in metastatic colorectal cancer (mCRC) patients treated with FOLFIRI/bevacizumab enrolled in FIRE3.
 
Satoshi Okazaki
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; Merck KGaA; Roche/Genentech; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Merck KGaA; Roche/Genentech
Travel, Accommodations, Expenses - Merck KGaA; Roche/Genentech
 
Volker Heinemann
Honoraria - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck KGaA; Roche Pharma AG; Sanofi
Research Funding - Amgen; Merck Serono; Pfizer; Roche Pharma AG
 
Shu Cao
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Dongyun Yang
No Relationships to Disclose
 
Yan Ning
No Relationships to Disclose
 
Yu Sunakawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
 
Stefan Stremitzer
No Relationships to Disclose
 
Satoshi Matsusaka
No Relationships to Disclose
 
Rita Elkhoueiry
No Relationships to Disclose
 
Angela Mendez
No Relationships to Disclose
 
Anish Parekh
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Celgene; Merck Serono; Roche Pharma AG
Consulting or Advisory Role - Bayer; Celgene; Merck Serono; Roche Pharma AG
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche Pharma AG